To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Secondary offerings announced by ...
Johnson & Johnson and Genmab both used the festive period to junk therapies that haven’t lived up to their promise in the clinic. J&J had been evaluating JNJ-95475939, an inhibitor of IL-4 and IL-31, ...
After a weak first half, the drug and biotech sector regained momentum in the latter part of 2025, setting the stage for a strong year for select stocks. Improved policy clarity following most large ...
The average prices of polysilicon, wafers, solar cells, and modules had risen by 38.9%, 2.2%, 0.4%, and 2.3% year-to-date. Image: PV Tech The Chinese PV industry has witnessed a wave of collective ...
Add Yahoo as a preferred source to see more of our stories on Google. If you’re a Stranger Things fan who still needs to watch Volume 1 of Season 5 before Volume 2 drops this week, but you need a ...
A wave of China out-licensing deals is feeding a biotech comeback in Hong Kong, where IPOs and follow-on placements are surging Hong Kong's biotech fundraising momentum is expected to extend into 2026 ...
Wide receiver Puka Nacua's touchdown, defensive end Braden Fiske's sack & more | Best of Los Angeles Rams' NFC Championship matchup against the Seattle Seahawks Browse through photos of the Los ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results